For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

USPTO Granted Patents = 10

EPO Patents = 2

Trademarks = 2

Forward Citations = 22

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Patrick Y Lu (9 out of 20 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. Alan Y Lu (2 out of 2 patents)

6. David M Evans (2 out of 2 patents)

7. Qingfeng Li (1 out of 5 patents)

8. Yibin Cai (1 out of 1 patent)

9. Qing Ge (1 out of 1 patent)

10. Bojian Zheng (1 out of 6 patents)

11. Qingquan Tang (1 out of 1 patent)

12. Martin Woodle (1 out of 7 patents)

13. Jia Zhou (1 out of 1 patent)

14. Ling Li (1 out of 1 patent)

15. Xiaoyong Lu (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12378552 - Oligomeric compound for inhibiting expression of factor XI (2025-08-05),

2. 12054714 - Peptide docking vehicle for targeted nucleic acid delivery (2024-08-06),

3. 12006500 - Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) (2024-06-11),

4. 11697813 - Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis (2023-07-11),

5. 11058779 - Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection (2021-07-13),

6. RE46873 - Multi-targeted RNAi therapeutics for scarless wound healing of skin (2018-05-28),

7. 9868952 - Compositions and methods for 'resistance-proof' SiRNA therapeutics for influenza (2018-01-16),

8. 9642873 - Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application (2017-05-09),

9. 9506063 - SiRNA compositions and methods for treatment of HPV and other infections (2016-11-29),

10. 8691781 - Compositions for treating respiratory viral infections and their use (2014-04-08),

Sirnaomics, Inc. is a leading clinical-stage biopharmaceutical company in the field of RNAi therapeutics. The company focuses on the discovery and development of innovative RNAi-based therapeutics for the treatment of various diseases, including cancer and fibrotic diseases. With a strong pipeline of potential therapies and a commitment to advancing precision medicine, Sirnaomics is poised to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#44 in Gaithersburg, MD

#403 in Maryland

#29,006 in US

#54,324 in the World

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

Forward Citations = 22

20 inventors:

Patrick Y Lu (9 out of 20 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. Alan Y Lu (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…